Comorbidity and early diagnosis of head and neck cancer in a medicare population

被引:22
|
作者
Reid, BC
Warren, JL
Rozier, G
机构
[1] Univ Maryland, Sch Dent, Dept Hlth Promot & Policy, Hlth Serv Res Program, Baltimore, MD 21201 USA
[2] Natl Canc Inst, Applied Res Program, Bethesda, MD USA
[3] Univ N Carolina, Dept Hlth Policy & Adm, Sch Publ Hlth, Chapel Hill, NC USA
关键词
D O I
10.1016/j.amepre.2004.07.018
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: This study assessed potential opportunities for an early diagnosis of head and neck cancers (HNCA), and the role played by comorbidity, among contacts by Medicare patients with the healthcare system before their diagnosis. Comorbidity was hypothesized to affect the relationship between use of healthcare services and stage of disease. Methods: The study database (n = 11,312) was constructed by linking files from the Surveillance, Epidemiology, and End Results Program 1991 through 1999 and those of the Center for Medicare and Medicaid Services Program. HNCA cases were comprised of the lip, oral cavity, pharynx, and larynx anatomic sites. Results: Among persons with no alcohol and tobacco-related comorbidities (ATC), increasing numbers of physician visits were independently associated with a reduced risk of advanced stage at diagnosis for all anatomic sites, but especially the pharynx and larynx. Among persons with one or more ATC, physician visits displayed no association with stage at diagnosis with the exception of laryngeal tumors, where physician visits were strongly associated with reduced risk of late stage at diagnosis. Over 46% of cases with advanced stage tumors, most of whom also had ATC disease, had greater than or equal to11 physician visits in the year preceding their diagnosis of HNCA. Conclusions: Potential opportunities for an earlier diagnosis of HNCA were found among the numerous contacts with the healthcare system that patients had prior to their cancer diagnosis. Such opportunities were especially numerous and relevant for persons with ATC and form the basis for combining high-risk with opportunistic screening approaches. (C) 2004 American journal of Preventive Medicine.
引用
收藏
页码:373 / 378
页数:6
相关论文
共 50 条
  • [21] DIAGNOSIS OF HEAD AND NECK CANCER
    SMITH, R
    JOURNAL OF THE OKLAHOMA STATE MEDICAL ASSOCIATION, 1974, 67 (04): : 128 - 133
  • [22] Differential prognostic impact of comorbidity in head and neck cancer
    Alho, Olli-Pekka
    Hannula, Kalle
    Luokkala, Antti
    Teppo, Heikki
    Koivunen, Petri
    Kantola, Saara
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2007, 29 (10): : 913 - 918
  • [23] Comparison of comorbidity indices for patients with head and neck cancer
    Piccirillo, JF
    Spitznagel, EL
    Vermani, N
    Costas, I
    Schnitzler, M
    MEDICAL CARE, 2004, 42 (05) : 482 - 486
  • [24] Significance and prognostic impact of comorbidity in head and neck cancer
    Kazi, Rehan
    Nutting, Chris M.
    Rhys-Evans, Peter
    Harrington, Kevin J.
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2009, 5 (03) : 145 - 147
  • [25] Role of comorbidity on outcome of head and neck cancer: a population-based study in Thuringia, Germany
    Goellnitz, Irene
    Inhestern, Johanna
    Wendt, Thomas G.
    Buentzel, Jens
    Esser, Dirk
    Boeger, Daniel
    Mueller, Andreas H.
    Piesold, Joern-Uwe
    Schultze-Mosgau, Stefan
    Eigendorff, Ekkehard
    Schlattmann, Peter
    Guntinas-Lichius, Orlando
    CANCER MEDICINE, 2016, 5 (11): : 3260 - 3271
  • [26] Early mortality after Head and Neck cancer diagnosis - Who and Why?
    Talani, C.
    Farnebo, L.
    Makitie, A.
    Laurell, G.
    RADIOTHERAPY AND ONCOLOGY, 2019, 132 : 82 - 82
  • [27] Association between comorbidity and survival in head and neck cancer: Results from Head and Neck 5000
    Schimansky, Sarah
    Lang, Samantha
    Beynon, Rhona
    Penfold, Christopher
    Davies, Amy
    Waylen, Andrea
    Thomas, Steve
    Pring, Miranda
    Pawlita, Michael
    Waterboer, Tim
    Ness, Andy
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (04): : 1053 - 1062
  • [28] Molecular diagnosis of head and neck cancer
    van Houten, VMM
    van den Brekel, MWM
    Denkers, F
    Colnot, DR
    Westerga, J
    van Diest, PJ
    Snow, GB
    Brakenhoff, RH
    LYMPHATIC METASTASIS AND SENTINEL LYMPHONODECTOMY, 2000, 157 : 90 - 106
  • [29] SURGICAL DIAGNOSIS IN CANCER OF THE HEAD AND NECK
    ROYSTER, HP
    SURGICAL CLINICS OF NORTH AMERICA, 1952, 32 (06) : 1599 - 1616
  • [30] OFFICE DIAGNOSIS OF CANCER OF THE HEAD AND NECK
    HARDIN, JC
    AMERICAN JOURNAL OF SURGERY, 1959, 97 (03): : 300 - 306